5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole
C19H13ClFN3O3 — CID 118161904
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole
5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole (PubChem CID 118161904) has the molecular formula C19H13ClFN3O3 and a molecular weight of 385.78 g/mol. Its IUPAC name is 5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole.
Molecular Properties
| Compound Name | 5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole |
|---|---|
| PubChem CID | 118161904 |
| Molecular Formula | C19H13ClFN3O3 |
| Molecular Weight | 385.78 g/mol |
| Exact Mass | 385.06 |
| IUPAC Name | 5-(4-chloro-3-fluorophenyl)-6-methoxy-3-(pyrimidin-2-ylmethoxy)-1,2-benzoxazole |
| SMILES | COc1cc2onc(OCc3ncccn3)c2cc1-c1ccc(Cl)c(F)c1 |
| InChI | InChI=1S/C19H13ClFN3O3/c1-25-16-9-17-13(8-12(16)11-3-4-14(20)15(21)7-11)19(24-27-17)26-10-18-22-5-2-6-23-18/h2-9H,10H2,1H3 |
| InChIKey | UZSZPHAGIRJBIH-UHFFFAOYSA-N |
| XLogP | 4.66 |
| TPSA | 70.27 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.78 |
| LogP ≤ 5 | 4.66 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 118161904 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.